Strategy & Portfolio Leader

Chez Roche, vous pouvez être vous-même et être apprécié pour les qualités uniques que vous apportez. Notre culture encourage l'expression personnelle, le dialogue ouvert et les connexions authentiques, où vous êtes valorisé, accepté et respecté pour ce que vous êtes, vous permettant de prospérer tant personnellement que professionnellement. Voici comment nous visons à prévenir, arrêter et guérir les maladies et à garantir à chacun l'accès aux soins de santé aujourd'hui et pour les générations à venir.

Rejoignez Roche, où chaque voix compte.

In Roche’s Pharmaceutical Research and Early Development organization (pRED), we make transformative medicines for patients in order to tackle some of the world’s toughest unmet healthcare needs. At pRED, we are united by our mission to transform science into medicines. Together, we create a culture defined by curiosity, responsibility, and humility, where our talented people are empowered and inspired to bring forward extraordinary life-changing innovation at speed.

Strategy, Portfolio & Operations (SPO) is a unified function that serves as the strategic and operational backbone enabling pRED's strategy from lab to clinic. Operating under a dynamic Chapter Model, SPO centralizes specialized skills across critical areas including Sites & Lab Services, Program & Project Management, Strategy, Clinical Operations, External Operations, Capability Development, Core Lab Technology Platforms (360

Labs) and Asset Team Leadership. SPO’s mission is to drive enterprise value creation by delivering operational excellence, and accelerating portfolio productivity. As a trusted partner, SPO fosters a culture of collaboration and accountability to ensure pRED transitions assets smoothly from early research to late stage development.

The Strategy & Portfolio (S&P) chapter acts as pRED’s strategic "engine room". The Chapter provides strategic consulting across internal and cross-Roche initiatives, using systems thinking to connect different areas of the business. Additionally, we design and manage critical governance boards while maintaining the organization's "single source of truth" data systems. This data is used to generate portfolio analytics and reports, root cause analyses, and pipeline projections for leadership.

Ultimately, our core mission is to shape the future of the business and enable data-driven, high-quality decisions that optimize efficiency and drive overall portfolio productivity.

We are offering an outstanding opportunity to support and augment the ongoing strategy activities within the Strategy and Portfolio Chapter (S&P) of SPO. This is a unique opportunity to join a high-impact group, working with multidisciplinary teams and acting as an independent and objective thought-partner to senior stakeholders on a range of business and strategic questions related to the overall direction and long-term strategy of pRED.

In this position, your responsibilities will include:

• Supporting the ongoing dialogue of the pRED strategy.
• Translate strategy into guidance for decision making at the pRED Leadership Team (pLT), and within the Disease Translational Areas or Global Functions (GFx)..
• Support senior pRED leadership (pLT and/or DTA / GFx LTs) and enhance decision making, specifically focusing on clarifying the right problem statement.
• Evolve the strategic priorities and initiatives to meet the holistic needs across pRED and establish a pRED-wide perspective on the portfolio strategy and priorities.
• Facilitate and lead communication efforts to ensure pRED wide understanding of strategy and portfolio context and be an ambassador and challenger for the portfolio voice across pRED.
• Facilitate an integrative and continuous dialogue across the pRED value chain to evaluate our strategy and implementation for the 3-5 year horizon and support leadership to navigate the portfolio to impact the Pharma vision.
• Consistently seek to evolve the strategic pRED wide perspective, external landscape evaluation for assets & technologies within Roche core DTAs and innovation assessment outside existing core diseases in close collaboration with Roche partnering.
• Supporti…